Routine bacterial screening of apheresis platelets on Day 4 using a rapid test: A 4-year single-center experience

Transfusion

Volumn 53, Issue 10, 2013, Pages 2307-2313

  Dunbar, Nancy M ^a   Kreuter, Justin D ^a   Marx Wood, Cynthia R ^a   Dumont, Larry J ^a   Szczepiorkowski, Zbigniew M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CELL SCREENING; FALSE POSITIVE RESULT; HUMAN; RAPID TEST; REPEAT PROCEDURE; RETROSPECTIVE STUDY; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD PLATELETS; HUMANS; PLATELET TRANSFUSION; PLATELETPHERESIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84885846511     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12083     Document Type: Article

References (24)

1. US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2011. Silver Spring (MD): US Food and Drug Administration. 2012. [cited 2012 Jun 15]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm302847.htm
2. Esber E,. Reduction of the maximum platelet storage period to 5 days in an approved container. Bethesda (MD): US Food and Drug Administration; 1986.
3. American Association of Blood Banks. Standards for blood banks and transfusion services. 27th ed. Bethesda (MD): American Association of Blood Banks; 2011.
4. Benjamin RJ, Dy B, Warren R, Lischka M, Eder AF,. Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets. Transfusion 2011; 51: 531-538.
5. McDonald CP,. Interventions implemented to reduce the risk of transmission of bacteria by transfusion in the English National Blood Service. Transfus Med Hemother 2011; 38: 255-258.
6. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ,; American Red Cross Regional Blood Centers. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47: 1134-1142. (Pubitemid 46934307)
7. de Korte D, Curvers J, de, Kort WL, Hoekstra T, van der, Poel CL, Beckers EA, Marcelis JH,. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006; 46: 476-485. (Pubitemid 43334104)
8. Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, Blades N,. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001; 41: 857-861. (Pubitemid 32642756)
9. Lozano M, Knutson F, Tardivel R, Cid J, Maymo RM, Lof H, Roddie H, Pelly J, Docherty A, Sherman C, Lin L, Propst M, Corash L, Prowse C,. A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion. Br J Haematol 2011; 153: 393-401.
10. De Wilde-Cherrier S, Meurou P, Marschner S, Reynaerts I,. Routine implementation of Mirasol PRT treated platelet concentrates in the Centre Hospitalier Luxemburg. Transfusion 2012; 52: 179A.
11. Schrezenmeier H, Walther-Wenke G, Muller TH, Weinauer F, Younis A, Holland-Letz T, Geis G, Asmus J, Bauerfeind U, Burkhart J, Deitenbeck R, Förstemann E, Gebauer W, Höchsmann B, Karakassopoulos A, Liebscher UM, Sänger W, Schmidt M, Schunter F, Sireis W, Seifried E,. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007; 47: 644-652. (Pubitemid 46449625)
12. Dumont LJ, Kleinman S, Murphy JR, Lippincott R, Schuyler R, Houghton J, Metzel P,. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010; 50: 589-599.
13. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadden E, Coakley P,. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008; 95: 13-19. (Pubitemid 351799415)
14. Pearce S, Rowe GP, Field SP,. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011; 21: 25-32.
15. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J,. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005; 88: 93-97. (Pubitemid 40362924)
16. Walther-Wenke G, Wirsing von Konig CH, Daubener W, Heiden M, Hoch J, Hornei B, Volkers P,; Working Party on Bacteria Safety in Transfusion Medicine, Advisory Board of the German Ministry of Health, Berlin. Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures. Vox Sang 2011; 100: 359-366.
17. Eder AF, Kennedy JM, Dy BA, Notari EP, Skeate R, Bachowski G, Mair DC, Webb JS, Wagner SJ, Dodd RY, Benjamin RJ,; American Red Cross Regional Blood Centers. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety. Transfusion 2009; 49: 1554-1563.
18. Jenkins C, Ramirez-Arcos S, Goldman M, Devine DV,. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51: 2555-2565.
19. Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE,; PGD Study Group. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011; 51: 2573-2582.
20. US Food and Drug Administration. Currently cleared CBER 510(k) clearances, as of December 03, 2012, sorted by applicant name. Silver Spring (MD): US Food and Drug Administration. 2012. [cited 2012 Dec 28]. Available from: URL: http://www.fda.gov/downloads/BiologicsBloodVaccines/ BloodBloodProducts/ApprovedProducts/ SubstantiallyEquivalent510kDeviceInformation/UCM149975.pdf
21. Verax Biomedical Incorporated. Platelet PGD test product insert. Worcester, MA: Verax Biomedical Incorporated. 2011. [cited 2012 Jun 28]. Available from: URL: http://www.veraxbiomedical.com/pdf/Platelet-PGD-Reagent-US. pdf
22. Ramirez-Arcos S, Kou Y, Mastronardi C, Perkins H, Goldman M,. Bacterial screening of outdated buffy coat platelet pools using a culture system and a rapid immunoassay. Transfusion 2011; 51: 2566-2572.
23. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) manual: guidelines and procedures for monitoring hemovigilance. Atlanta, GA: Centers for Disease Control and Prevention. June 2011. [cited 2012 Sep 12]. Available from: URL: http://www.cdc.gov/nhsn/PDFs/ Biovigilance/BV-Protocol-1-3-1-June-2011.pdf
24. Cooper L, Szczepiorkowski Z, Dumont LJ, AuBuchon JP,. Prospective evaluation of three protocols to integrate a rapid bacterial detection system into routine daily operations in a mid-sized transfusion service laboratory. Transfusion 2008; 48: 209A-210.